Business Context and Reporting Period
Company: Flora Growth Corp. (rebranding to ZeroStack Corp.)
Filing Type: Form 10-Q
Period: Quarter ended September 30, 2025
Flora Growth Corp. is transitioning from a global pharmaceutical distributor and legacy hemp/cannabis operator into a decentralized AI treasury company. The company focuses on strategic ownership of 0G Tokens (Zero Gravity Labs) to invest in AI infrastructure. During the quarter, the company completed the sale of its legacy hemp and cannabis business (classified as discontinued operations) and executed a significant PIPE offering to acquire digital assets.
Key Financial Metrics
| Metric (in thousands USD) | Q3 2025 | Q3 2024 | YTD 9M 2025 | YTD 9M 2024 |
|---|---|---|---|---|
| Revenue | $9,748 | $7,238 | $26,323 | $28,219 |
| Gross Profit | $335 | $495 | $1,489 | $1,910 |
| Gross Margin | 3.4% | 6.8% | 5.7% | 6.8% |
| Operating Loss | $(3,266) | $(2,116) | $(5,412) | $(5,222) |
| Net Loss (Continuing Ops) | $(3,627) | $(2,326) | $(5,507) | $(5,547) |
| Net Loss (Total) | $(6,659) | $(3,800) | $(9,829) | $(9,831) |
| Cash & Restricted Cash | $13,125 | $4,244 | $13,125 | $4,244 |
| Digital Assets (Total) | $55,406 | $0 | $55,406 | $0 |
| Total Debt (Current + Non-Current) | $2,761 | $2,080 | $2,761 | $2,080 |
Material Changes vs. Prior Period
- Strategic Pivot & Asset Composition: Total assets increased from $26.2 million (Dec 2024) to $74.0 million (Sep 2025), driven primarily by the acquisition of $55.4 million in digital assets (0G Tokens, Solana, etc.) via a PIPE offering. The company sold its legacy cannabis business, reclassifying those results as discontinued operations.
- Revenue & Margins: Q3 2025 revenue increased 35% year-over-year to $9.7 million, driven by the pharmaceutical distribution subsidiary (Phatebo). However, gross margin compressed to 3.4% from 6.8% in Q3 2024 due to an unfavorable product mix with lower-margin sales.
- Operating Expenses: Operating expenses rose to $3.6 million in Q3 2025 from $2.6 million in Q3 2024. This increase was largely due to a $0.6 million contingency loss related to a legal proceeding and increased share-based compensation ($0.5 million vs $0.4 million).
- Discontinued Operations: The company recorded a loss of $3.0 million from discontinued operations in Q3 2025, primarily due to a $1.4 million goodwill impairment at the former TruHC subsidiary prior to the sale.
- Liquidity: Cash balances more than doubled to $13.1 million following the September 2025 PIPE offering, which raised approximately $13.3 million in cash proceeds.
Guidance, Outlook, Risks, and Unusual Items
- Management Commentary: Management states that the company is now a "decentralized AI treasury company." The proceeds from the PIPE offering and a subsequent Zero Gravity Convertible Note are being used to acquire 0G Tokens. The company believes its current liquidity is sufficient for short and long-term obligations.
- Unusual Items:
- Gain on Deconsolidation: A $1.1 million gain was recorded in the nine months ended Sep 2025 due to the deconsolidation of insolvent subsidiaries (Franchise Global Health entities) that filed for bankruptcy in March 2025.
- Legal Settlement: The company settled a claim regarding JustCBD contingent consideration for $1.8 million, resulting in a $1.4 million charge recorded in "Other expenses, net."
- Share Consolidation: A 1-for-39 reverse stock split was effected on August 4, 2025, to regain compliance with Nasdaq minimum bid price requirements.
- Risks & Contingencies:
- Cryptocurrency Volatility: The company's financial results are now heavily exposed to the price volatility of 0G Tokens and other digital assets. A significant decline in 0G value could materially adversely affect the balance sheet and stock price.
- Regulatory Uncertainty: Risks include the potential classification of 0G Tokens as a "security" by the SEC, which could subject the company to the Investment Company Act of 1940. Additionally, the company faces risks regarding AI regulation impacting the 0G Blockchain.
- Corporate Governance: Following the passing of a director in August 2025, the Board is currently non-compliant with Nasdaq rules regarding the majority of independent directors and the minimum size of the audit committee. The company is evaluating options to regain compliance.
- Legal Proceedings: A $0.6 million provision was recorded for a lease dispute involving a former subsidiary (Vessel Brand Inc.).
Investor Verification Checklist
- Digital Asset Valuation: Verify the fair value methodology for the $55.4 million in digital assets (0G Tokens) and the specific exchange rates used, as these are Level 1 inputs subject to high volatility.
- Going Concern Status: Confirm that the cash raised in the PIPE offering ($13.3M) and the value of digital assets are sufficient to cover the $2.8M in debt due within 12 months and ongoing operating losses.
- Nasdaq Compliance: Monitor the company's progress in regaining compliance with Nasdaq Listing Rule 5605 regarding the majority of independent directors and audit committee composition.
- Legal Exposure: Review the status of the $0.6 million lease dispute and any potential indemnification claims related to the sale of the legacy cannabis business.
- Revenue Quality: Analyze the concentration of revenue within the Phatebo subsidiary and the sustainability of the compressed gross margins (3.4% in Q3).